Anti-angiogenic effect of metformin in human liver carcinogenesis related to metabolic syndrome

被引：13
作者：
Cauchy, Francois [1 ,2 ]
Mebarki, Mouniya [1 ]
Albuquerque, Miguel [3 ]
Laouirem, Samira [1 ]
Rautou, Pierre Emmanuel [4 ]
Soubrane, Olivier [2 ]
Raymond, Eric [5 ]
Bedossa, Pierre [1 ,3 ]
Paradis, Valerie [1 ,3 ]
机构：
[1] Paris Diderot Univ, Inflammat Res Ctr, INSERM, UMR1149, Paris, France
[2] Beaujon Hosp, AP HP, Hepatobiliary Surg & Liver Transplantat Dept, F-92110 Clichy, France
[3] Beaujon Hosp, AP HP, Dept Pathol, F-92110 Clichy, France
[4] Beaujon Hosp, AP HP, Hepatol Dept, F-92110 Clichy, France
[5] Beaujon Hosp, AP HP, Dept Oncol, F-92110 Clichy, France
来源：
GUT | 2015年 / 64卷 / 09期
关键词：
ANTIDIABETIC DRUG METFORMIN; HEPATOCELLULAR-CARCINOMA; IN-VITRO; RISK; CELLS; CANCER;
D O I：
10.1136/gutjnl-2015-310069
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1498 / 1500
页数：3
相关论文
共 10 条
  • [1] Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
    Chen, Hsiao-Ping
    Shieh, Jeng-Jer
    Chang, Chia-Che
    Chen, Tzu-Ting
    Lin, Jaw-Town
    Wu, Ming-Shiang
    Lin, Jeng-Horng
    Wu, Chun-Ying
    [J]. GUT, 2013, 62 (04) : 606 - 615
  • [2] Paradoxic effects of metformin on endothelial cells and angiogenesis
    Dallaglio, Katiuscia
    Bruno, Antonino
    Cantelmo, Anna R.
    Esposito, Alessia I.
    Ruggiero, Luca
    Orecchioni, Stefania
    Calleri, Angelica
    Bertolini, Francesco
    Pfeffer, Ulrich
    Noonan, Douglas M.
    Albini, Adriana
    [J]. CARCINOGENESIS, 2014, 35 (05) : 1055 - 1066
  • [3] Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment
    Giannelli, Gianluigi
    Rani, Bhavna
    Dituri, Francesco
    Cao, Yuan
    Palasciano, Giuseppe
    [J]. GUT, 2014, 63 (10) : 1668 - 1676
  • [4] Effect of the anti-diabetic drug metformin in hepatocellular carcinoma in vitro and in vivo
    Miyoshi, Hisaaki
    Kato, Kiyohito
    Iwama, Hisakazu
    Maeda, Emiko
    Sakamoto, Teppei
    Fujita, Koji
    Toyota, Yuka
    Tani, Joji
    Nomura, Takako
    Mimura, Shima
    Kobayashi, Mitsuyoshi
    Morishita, Asahiro
    Kobara, Hideki
    Mori, Hirohito
    Yoneyama, Hirohito
    Deguchi, Akihiro
    Himoto, Takashi
    Kurokohchi, Kazutaka
    Okano, Keiichi
    Suzuki, Yasuyuki
    Murao, Koji
    Masaki, Tsutomu
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 45 (01) : 322 - 332
  • [5] Metformin Inhibits Angiogenesis Induced by Interaction of Hepatocellular Carcinoma with Hepatic Stellate Cells
    Qu, Hongmei
    Yang, Xingwang
    [J]. CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 71 (02) : 931 - 936
  • [6] Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
    Singh, Siddharth
    Singh, Preet Paul
    Singh, Abha Goyal
    Murad, Mohammad Hassan
    Sanchez, William
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (06) : 881 - 891
  • [7] Metformin and risk of hepatocellular carcinoma: are statins the missing link?
    Singh, Siddharth
    Singh, Preet Paul
    [J]. GUT, 2013, 62 (06) : 951 - 952
  • [8] Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
    Starley, Brad Q.
    Calcagno, Christopher J.
    Harrison, Stephen A.
    [J]. HEPATOLOGY, 2010, 51 (05) : 1820 - 1832
  • [9] The anti-diabetic drug metformin inhibits vascular endothelial growth factor expression via the mammalian target of rapamycin complex 1/hypoxia-inducible factor-1α signaling pathway in ELT-3 cells
    Tadakawa, Mad
    Takeda, Takashi
    Li, Bin
    Tsuiji, Kenji
    Yaegashi, Nobuo
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 399 (0C) : 1 - 8
  • [10] Metabolic Syndrome Increases the Risk of Primary Liver Cancer in the United States: A Study in the SEER-Medicare Database
    Welzel, Tania M.
    Graubard, Barry I.
    Zeuzem, Stefan
    El-Serag, Hashem B.
    Davila, Jessica A.
    McGlynn, Katherine A.
    [J]. HEPATOLOGY, 2011, 54 (02) : 463 - 471
1